Share Name Share Symbol Market Type Share ISIN Share Description
International Biotechnology Trust LSE:IBT London Ordinary Share GB0004559349 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -8.00p -1.34% 588.00p 590.00p 598.00p 608.00p 592.00p 606.00p 40,050 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 -1.8 -5.1 - 222.69

International Biotechnology Share Discussion Threads

Showing 226 to 247 of 475 messages
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
03/4/2013
10:46
Date NAV Pence Tuesday 02 Apr Ex Income 284.85
davebowler
26/3/2013
06:32
Interesting, thanks, wonder what policy applies to other Bio trusts.
philo124
25/3/2013
20:41
NAV up 6.5p see later RNS
davebowler
14/3/2013
11:15
NAV Wednesday 13 Mar Ex Income 276.31
davebowler
11/3/2013
18:47
Should have topped up last week, it was a no-brainer.
philo124
07/3/2013
14:59
NAV Wednesday 06 Mar 269.68
davebowler
05/3/2013
12:35
NAV Monday 04 Mar Ex Income 264.17
davebowler
20/2/2013
10:17
V good value.
philo124
19/2/2013
11:05
Monday 18 Feb NAV Ex Income 252.37
davebowler
12/2/2013
14:43
NAV c248p.
philo124
29/1/2013
12:56
Date NAV Pence Monday 28 Jan Ex Income 251.45
davebowler
21/1/2013
18:51
Yep, agreed sit it with a chunky of GSK to balance yield.
philo124
21/1/2013
17:15
one for my Sipp, ticks the boxes, performance, discount and prepared to ignore the yield
127tolmers
19/1/2013
22:21
http://www.ibtplc.com/assets/images/IBT%20Presentation%20AGM_05Dec12.pdf
davebowler
19/1/2013
22:17
http://www.ibtplc.com/fact_sheets/2012/December2012.pdf
davebowler
17/1/2013
13:46
BIOG is at a 1% premium http://www.trustnet.com/Factsheets/Factsheet.aspx?fundCode=AKFR0&univ=T whereas IBT (similar) is at a 16% discount.http://www.trustnet.com/Factsheets/Factsheet.aspx?fundCode=ITIBT&univ=T
davebowler
13/12/2012
16:52
Bought for SIPP; already hold BIOG & PCGH.
philo124
07/12/2012
14:17
http://www.edisoninvestmentresearch.co.uk/sectorreports/HealthcareQuarterly_Dec12.pdf
davebowler
26/11/2012
14:42
Ridiculously cheap at 17% discount to NAV compared to similar BIOG at 5% discount.
davebowler
23/11/2012
16:55
Why the recent decline in the s.p.? Profit taking?
gilston
19/10/2012
14:22
Good results today persuaded me to buy. A few key bits. "Investment Performance In this, my first letter to shareholders as Chairman, I am pleased to report to you a substantial positive return for the year ended 31 August 2012. The NAV increased by 41.9% to 232.5p per share. With a small narrowing of the discount to 12.0% from 12.7%, the Company's share price increased by 43.0%. By comparison, the FTSE All-Share Index produced a total return of just 10.2% over the same period. For the first time in several years, positive absolute performance was generated from both the quoted and unquoted parts of the portfolio, with a 47.8% and 21.7% increase for each, respectively. Investor enthusiasm for the biotechnology sector improved dramatically over the period against the backdrop of positive, yet muted, price gains for the broader stock market. With the Company's share price currently trading at a 12.0% discount to NAV, and the unquoted portfolio comprising 16.0% of overall NAV, the market is assigning little value to the unquoted portfolio. The Board believes this represents a valuation anomaly and offers investors an excellent opportunity to become Shareholders in the biotechnology industry's quiet revolution, even after the quoted sector's recent very strong run. The Company currently recognises GBP0.7m of fair value for future milestone payments potentially due to the Company from unquoted investments already exited. The receipt of these payments is contingent on pre-agreed, and legally-binding, operational or clinical development milestones being achieved. If paid in full, these milestone payments would amount to GBP9.6m on current exchange rates, representing GBP8.8m of additional unrecognised value."
127tolmers
27/9/2012
11:54
Bullish outlook; http://www.internationalbiotrust.com/press_releases/Biotech.pdf
davebowler
Chat Pages: 19  18  17  16  15  14  13  12  11  10  9  8  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180525 03:21:37